1. Home
  2. BLFY vs LXRX Comparison

BLFY vs LXRX Comparison

Compare BLFY & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFY
  • LXRX
  • Stock Information
  • Founded
  • BLFY 1939
  • LXRX 1995
  • Country
  • BLFY United States
  • LXRX United States
  • Employees
  • BLFY N/A
  • LXRX N/A
  • Industry
  • BLFY Commercial Banks
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLFY Finance
  • LXRX Health Care
  • Exchange
  • BLFY Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • BLFY 204.2M
  • LXRX 228.8M
  • IPO Year
  • BLFY N/A
  • LXRX 2000
  • Fundamental
  • Price
  • BLFY $9.38
  • LXRX $1.08
  • Analyst Decision
  • BLFY Hold
  • LXRX Buy
  • Analyst Count
  • BLFY 2
  • LXRX 4
  • Target Price
  • BLFY $11.00
  • LXRX $3.67
  • AVG Volume (30 Days)
  • BLFY 60.2K
  • LXRX 5.0M
  • Earning Date
  • BLFY 07-30-2025
  • LXRX 07-31-2025
  • Dividend Yield
  • BLFY N/A
  • LXRX N/A
  • EPS Growth
  • BLFY N/A
  • LXRX N/A
  • EPS
  • BLFY N/A
  • LXRX N/A
  • Revenue
  • BLFY $41,228,000.00
  • LXRX $31,213,000.00
  • Revenue This Year
  • BLFY $20.14
  • LXRX N/A
  • Revenue Next Year
  • BLFY $20.20
  • LXRX N/A
  • P/E Ratio
  • BLFY N/A
  • LXRX N/A
  • Revenue Growth
  • BLFY N/A
  • LXRX 1251.21
  • 52 Week Low
  • BLFY $8.34
  • LXRX $0.28
  • 52 Week High
  • BLFY $11.48
  • LXRX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • BLFY 49.32
  • LXRX 66.94
  • Support Level
  • BLFY $9.49
  • LXRX $0.84
  • Resistance Level
  • BLFY $10.00
  • LXRX $1.19
  • Average True Range (ATR)
  • BLFY 0.30
  • LXRX 0.09
  • MACD
  • BLFY 0.01
  • LXRX 0.02
  • Stochastic Oscillator
  • BLFY 47.01
  • LXRX 76.60

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: